|
Main | | | | | | | | | | | |
| Brand Name | Vytorin | | | | | | | | | |
| Clinical Trials | | | | | | | | | | |
| | Phase III "IMPROVE-IT" - results in 2012 or 2013? N=18000 | | | | | | | | | |
| | Vytorin vs Simvastatin. Still recruiting as of 11/09. | | | | | | | | | |
| | | | | | | | | | | |
| | Phase III SEAS | | | | | | | | | |
| | 22T RRR in atherosclerotic events. | | | | | | | | | |
| | 105 vs 70 cancer findings, p=0.01 and HR=1.67 cancer deaths. | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| Rx | | Vytorin | Zetia | Zocor+Simva | Lipitor | Crestor | Pravastatin | Lovastatin | Caduet | Total |
| | 12/4/2009 | | | | | | | | | |
| | 11/27/2009 | | | | | | | | | |
| | 11/20/2009 | | | | | | | | | |
| | 11/13/2009 | | | | | | | | | |
| | 11/6/2009 | | | | | | | | | |
| | 10/30/2009 | | | | | | | | | |
| | 10/23/2009 | 264541 | 259754 | 1919054 | 1234272 | 542200 | 388439 | 300593 | 56784 | 4965637 |
| | 10/16/2009 | 257895 | 254143 | 1854237 | 1201641 | 524453 | 374173 | 289187 | 55575 | 4811304 |
| | 10/9/2009 | 268125 | 264951 | 1927398 | 1255623 | 539816 | 392268 | 305485 | 58919 | 5012585 |
| | 10/2/2009 | 282165 | 276199 | 2009078 | 1311075 | 562927 | 409841 | 320878 | 61715 | 5233878 |
| | 9/25/2009 | 270801 | 264711 | 1909664 | 1256450 | 542271 | 390436 | 303956 | 58411 | 4996700 |
| | 9/18/2009 | 275754 | 267620 | 1924380 | 1273950 | 544488 | 393494 | 304228 | 59176 | 5043090 |
| | 9/11/2009 | 254453 | 246575 | 1796661 | 1178898 | 502323 | 363576 | 289942 | 55572 | 4688000 |
| | 9/4/2009 | 291613 | 282178 | 2017381 | 1344473 | 569945 | 410389 | 329232 | 63709 | 5308920 |